Mr McAuliffe is an experienced board director and entrepreneur who has over twenty years’ experience in the international biotechnology field. He has been involved in numerous capital raisings and in-licensing of technologies. He is a founder of several companies in Australia, France and the United Kingdom, many of which have become public companies. Mr McAuliffe has an Honours degree in Law, a Bachelor of Pharmacy degree and is the President of the Dyslexia – Speld Foundation WA (Inc). Mr McAuliffe is a current director of 4DS Memory Ltd.

Dr Duthy has over 15 years of direct financial markets experience having worked in sell-side equity research, and senior executive roles across investor relations and corporate development. Dr Duthy is the Founder and CEO of Nemean Group Pty Ltd, a boutique corporate advisory and investor relations firm specialising in delivering value-added services across the life sciences, medical devices, healthcare, technology and emerging companies sectors. Prior to establishing Nemean in October 2018, Tom was the Global Head of Investor Relations & Corporate Development at Sirtex Medical Limited (ASX:SRX), which was sold to CDH Investments in September 2018 for A$1.9 billion and remains the largest medical device transaction in Australian corporate history. Prior to Sirtex, Tom spent ten years as a leading sell-side Healthcare & Biotechnology analyst at Taylor Collison Limited, focused mainly on small cap companies. During this time, approximately $200 million in equity capital was raised for selected portfolio companies. He is a Member of the Australian Institute of Company Directors (MAICD) and the Australasian Investor Relations Association (AIRA).

David has more than 30 years of Senior Executive Management, Directorships, and Corporate Advisory experience. He is a foundation Director and Partner of Pathways Corporate a boutique Corporate Advisory firm that undertakes assignments on behalf of family offices, private clients, and ASX listed companies. David is a Fellow of the Australian Institute of Company Directors (FAICD). He is currently Non-Executive Chairman of Protean Energy Ltd, PVW Resources Ltd and Avira Resources Ltd and a Non-Executive Director of Ragnar Metals Ltd, Tyranna Resources Ltd, MOAB Ltd, Cycliq Group Ltd, Cradle Resources Ltd and OZZ Resources Ltd.

Narelle Warren has over twenty years corporate advisory, financial management and company secretarial experience with particular emphasis on small to mid-cap listed companies in the resources, energy and biotech sectors. Narelle works closely with the Board of Directors on strategic and business planning, funding strategies, incentive planning, corporate governance and general financial management. Since 2005 Narelle has worked as a self-employed Consultant on a project basis specialising in the co-ordination and management of acquisitions, trade sales, capital raisings and associated due diligence procedures as well as the provision of company secretarial and financial management services. During this time, Narelle has also been involved as a founder of a number of companies and assisted in raising funds via private and public equity markets. Prior to this Narelle was employed by a corporate advisory group in Perth, HSBC in London and KPMG Perth. Narelle is qualified as a Chartered Accountant and holds both a Bachelor of Laws and Bachelor of Commerce.